Browsing by Subject "montelukast"
Now showing items 1-8 of 8
-
Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea
(2008)Background: Increased expression of cysteinyl leukotriene receptors (cysteinyl leukotriene receptor-1 [LT1-R]; cysteinyl leukotriene receptor-2 [LT2-R]) has been detected in adenotonsillar tissue from children with ... -
ERS statement on obstructive sleep disordered breathing in 1- to 23-month-old children
(2017)The present statement was produced by a European Respiratory Society Task Force to summarise the evidence and current practice on the diagnosis and management of obstructive sleep disordered breathing (SDB) in children ... -
Leukotriene antagonists: As firstline asthmatic therapy: A review
(2005)Asthma is a chronic inflammatory disorder characterized by airflow obstruction. The development of leukotriene receptor antagonists and synthesis inhibitors in briefly described; and acute exercise, allergen, and aspirin ... -
Leukotriene-receptor antagonists versus placebo in the treatment of asthma in adults and adolescents a systematic review and meta-analysis
(2015)Background: Leukotriene-receptor antagonists (LTRAs) are recommended as an alternative treatment in patients with mild asthma, but their effect compared with placebo is unclear. Purpose: To determine the benefits and harms ... -
Obstructive sleep disordered breathing in 2- to 18-year-old children: Diagnosis and management
(2016)This document summarises the conclusions of a European Respiratory Society Task Force on the diagnosis and management of obstructive sleep disordered breathing (SDB) in childhood and refers to children aged 2-18 years. ... -
Takotsubo cardiomyopathy: A known unknown foe of asthma
(2017)Introduction: Patients with uncontrolled asthma are at a greater risk of asthma attacks requiring emergency room visits or hospital admissions. Takotsubo cardiomyopathy is potentially a significant complication in a course ...